Search details
1.
Hepatoprotective effect of N-acetylcysteine in trabectedin-induced liver toxicity in patients with advanced soft tissue sarcoma.
Support Care Cancer
; 26(8): 2929-2935, 2018 Aug.
Article
in English
| MEDLINE | ID: mdl-29546526
2.
Clinical validity of circulating tumour cells in patients with metastatic breast cancer: a pooled analysis of individual patient data.
Lancet Oncol
; 15(4): 406-14, 2014 Apr.
Article
in English
| MEDLINE | ID: mdl-24636208
3.
Idiopathic intracranial hypertension: a possible complication in the natural history of advanced prostate cancer.
Int J Urol
; 21(3): 335-7, 2014 Mar.
Article
in English
| MEDLINE | ID: mdl-24107135
4.
Feasibility and Activity of Megestrol Acetate in Addition to Etoposide, Doxorubicin, Cisplatin, and Mitotane as First-Line Therapy in Patients with Metastatic/Unresectable Adrenocortical Carcinoma with Low Performance Status.
Cancers (Basel)
; 15(18)2023 Sep 09.
Article
in English
| MEDLINE | ID: mdl-37760461
5.
Impaired activation of plasmacytoid dendritic cells via toll-like receptor 7/9 and STING is mediated by melanoma-derived immunosuppressive cytokines and metabolic drift.
Front Immunol
; 14: 1227648, 2023.
Article
in English
| MEDLINE | ID: mdl-38239354
6.
Outcomes in patients with BRAFV600-mutated melanoma and brain metastases at baseline treated with dabrafenib plus trametinib.
Tumori
; 109(6): 537-545, 2023 Dec.
Article
in English
| MEDLINE | ID: mdl-37417313
7.
The Pattern of Progression to First-Line Treatment with Dabrafenib and Trametinib in Patients with Unresectable or Metastatic, BRAF-Mutated, Cutaneous Melanoma: Results of the Observational T-WIN Study.
Cancers (Basel)
; 15(7)2023 Mar 26.
Article
in English
| MEDLINE | ID: mdl-37046641
8.
Characteristics of Real-World Patients with High-Risk BRAFV600E/K-Mutated Melanoma Receiving Adjuvant Treatment with Dabrafenib Plus Trametinib After Surgical Resection, Through the Italian Managed Access Program.
Cancer Manag Res
; 15: 1271-1281, 2023.
Article
in English
| MEDLINE | ID: mdl-38027240
9.
Italian nivolumab Expanded Access Programme in melanoma adjuvant setting: patient outcomes and safety profile.
Eur J Cancer
; 191: 113246, 2023 09.
Article
in English
| MEDLINE | ID: mdl-37549531
10.
Involvement of target gene polymorphisms in 5-Fluorouracil toxicity: a case report.
Pharmacology
; 89(1-2): 99-102, 2012.
Article
in English
| MEDLINE | ID: mdl-22343422
11.
Supportive therapies in patients with advanced adrenocortical carcinoma submitted to standard EDP-M regimen.
Endocrine
; 77(3): 438-443, 2022 09.
Article
in English
| MEDLINE | ID: mdl-35567656
12.
Comparison Between First Line Target Therapy and Immunotherapy in Different Prognostic Categories of BRAF Mutant Metastatic Melanoma Patients: An Italian Melanoma Intergroup Study.
Front Oncol
; 12: 917999, 2022.
Article
in English
| MEDLINE | ID: mdl-36046043
13.
What to Do and What Not to Do in the Management of Cancer Pain: A Physician Survey and Expert Recommendations.
Cancer Manag Res
; 13: 5203-5210, 2021.
Article
in English
| MEDLINE | ID: mdl-34234563
14.
Outcome of patients with intrathyroidal thymic carcinoma: a pooled analysis.
Endocr Relat Cancer
; 28(8): 593-604, 2021 07 05.
Article
in English
| MEDLINE | ID: mdl-34105516
15.
Efficacy of Immune Checkpoint Inhibitors in Rare Tumours: A Systematic Review.
Front Immunol
; 12: 720748, 2021.
Article
in English
| MEDLINE | ID: mdl-34616395
16.
Accurate Triage of Oncological Patients for Safely Continuing Cancer Therapy During the SARS-CoV-2 Pandemic.
Front Oncol
; 11: 707346, 2021.
Article
in English
| MEDLINE | ID: mdl-34722252
17.
A Retrospective Analysis of Dabrafenib and/or Dabrafenib Plus Trametinib Combination in Patients with Metastatic Melanoma to Characterize Patients with Long-Term Benefit in the Individual Patient Program (DESCRIBE III).
Cancers (Basel)
; 13(10)2021 May 18.
Article
in English
| MEDLINE | ID: mdl-34070224
18.
Retrospective Chart Review of Dabrafenib Plus Trametinib in Patients with Metastatic BRAF V600-Mutant Melanoma Treated in the Individual Patient Program (DESCRIBE Italy).
Target Oncol
; 16(6): 789-799, 2021 11.
Article
in English
| MEDLINE | ID: mdl-34755244
19.
Human Plasmacytoid Dendritic Cells and Cutaneous Melanoma.
Cells
; 9(2)2020 02 11.
Article
in English
| MEDLINE | ID: mdl-32054102
20.
Should everolimus be stopped after radiological progression in metastatic insulinoma? A "cons" point of view.
Endocrine
; 69(3): 481-484, 2020 09.
Article
in English
| MEDLINE | ID: mdl-32488839